Table 2.

Quality metrics of stage 3 Chronic Kidney Disease registry after implementation of automated urinary albumin testing^a

Quality Metric	April 2018	April 2019	April 2020	p value
Albuminuria testing within 1 y, %	26.9	83	77	< 0.001
Albuminuria testing within 3 y, %	41.2	92.7	95.3	< 0.001
ACE inhibitor or ARB use, %	65.8	65.7	66.4	0.54
ACE inhibitor or ARB use with renal indications,b %	77.7	80.4	80.5	0.10
Hgba1c < 8%, %	79.3	79.5	78.2	0.28
BP < 140/90 mmHg, %	75.2	75.4	73.3	0.003

^a Automated urinary albumin testing was implemented May 2018.

^b Renal indication for ACE inhibitor or ARB defined as active diagnosis of hypertension and random urinary albumin creatinine ratio > 30 mg/g in diabetics or random urinary albumin creatinine ratio > 300 mg/g in nondiabetics.

ACE = angiotensin-converting enzyme; ARB, angiotensin receptor blocker; BP = blood pressure; Hgba1c = hemoglobin A1c.